eudamed_udi Primary ID: 06947145580605

MAGLUMI Tacrolimus (CLIA) Controls (UDI 06947145580605)

Manufactured by Shenzhen New Industries Biomedical Engineering Co., Ltd.

Data verified against official FDA/EUDAMED records on August 9, 2026

Scannable UDI-DI Representation

Device Regulatory Overview

The MAGLUMI Tacrolimus (CLIA) Controls (Model/Catalog Number: 1602011036MT) is a medical device manufactured by Shenzhen New Industries Biomedical Engineering Co., Ltd.. This product is indexed under FDA Product Code / Category Classification W0102152001 within international Unique Device Identification (UDI) compliance databases.

Technical Specifications

Model Number: 1602011036MT
Product Code / EMDN: W0102152001
Device Name: Tacrolimus (CLIA) Controls
Database Sync Date: 2026-08-09 18:49:15

Full Regulatory Attributes

🔒 Token Gated

{
    "review_panel": "AN",
    "gudid_di_status": "Published",
    "sterilization_methods": ["EO", "Gamma"],
    "rx_only": true
}

Unlock Compliance Data & Serialization Specs

Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.

Get API Token Access ($49/mo)

Frequently Asked Questions

Who is the primary manufacturer of MAGLUMI Tacrolimus (CLIA) Controls?

The registered manufacturer of record for MAGLUMI Tacrolimus (CLIA) Controls is Shenzhen New Industries Biomedical Engineering Co., Ltd..

What is the Primary UDI-DI identifier for MAGLUMI Tacrolimus (CLIA) Controls?

The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06947145580605.

What classification code is assigned to this device?

This device is registered under product classification code W0102152001.

Similar Classification Devices (W0102152001)

Other Devices by Shenzhen New Industries Biomedical Engineering Co., Ltd.

Programmatic Export

Export this master device record as standardized JSON or CSV for compliance audits.

JSON API Endpoint